Viruses 2016, 8(8), 222; doi:10.3390/v8080222
Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis
1
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse 31059, France
2
INSERM U1043, IFR–BMT, CHU Purpan, Toulouse 31000, France
3
University Toulouse III—Paul Sabatier, Toulouse 31000, France
4
Laboratory of Virology, CHU Purpan, Toulouse 31000, France
5
Department of Hepatology, CHU Purpan, Toulouse 31000, France
6
MR 152 IRD-Toulouse III University, Toulouse 31000, France
7
Internal Medicine-Digestive Department, CHU Purpan, Toulouse, 31000, France
*
Author to whom correspondence should be addressed.
Academic Editor: Eric O. Freed
Received: 28 June 2016 / Revised: 30 July 2016 / Accepted: 9 August 2016 / Published: 15 August 2016
(This article belongs to the Special Issue Recent Progress in Hepatitis E Virus Research)
Abstract
Hepatitis E virus (HEV) infection can cause hepatic and extra-hepatic manifestations. Treatment of HEV infection has been thoroughly studied in solid-organ-transplant patients who have developed a chronic HEV infection. In this review, we report on our current knowledge regarding treatment of HEV infection. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Kamar, N.; Lhomme, S.; Abravanel, F.; Marion, O.; Peron, J.-M.; Alric, L.; Izopet, J. Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis. Viruses 2016, 8, 222.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.